Mayo, T.; Armstrong, A. W.; Kircik, L.; Silverberg, J.; Blauvelt, A.; Esdalie, B.; Schneider, S.; Mark, T.; Gooderham, M.; Alexis, A. F. Efficacy and Safety of up to Two Years of Tralokinumab Treatment in Adults of Different Racial Subgroups With Moderate-to-Severe Atopic Dermatitis. J of Skin 2022, 6, s74.